Literature DB >> 8599232

Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnaviral genomes: key role of enhancer II.

K Ueda1, Y Wei, D Ganem.   

Abstract

Woodchuck hepatitis virus (WHV) is strongly oncogenic in its native host, producing hepatocellular carcinomas in the majority of chronically infected animals. An important step in this oncogenic process is the activation of N-myc transcription in the liver as a result of integration of viral sequences in cis to the N-myc2 locus. We have examined the viral sequences involved in the up-regulation of N-myc2 using transient transfection assays of permissive HepG2 cells in culture. WHV sequences corresponding to enhancer I of human hepatitis B virus are nearly inactive in N-myc2 activation when tested alone and are not significantly activated by WHV X gene coexpression. By contrast, sequences corresponding to enhancer II strongly activate expression in a position and orientation-independent manner and are only modestly further up-regulated by WHx expression. Qualitatively similar results were observed with sequences of the ground squirrel hepatitis virus (GSHV), which produces hepatomas in woodchucks without insertional activation of N-myc2, but the GSHV EnII element is fourfold less active in N-myc2 up-regulation than its WHV counterpart.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599232     DOI: 10.1006/viro.1996.0133

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

Authors:  R Zufferey; J E Donello; D Trono; T J Hope
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II.

Authors:  K Ueda; Y Wei; D Ganem
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

Authors:  J E Donello; J E Loeb; T J Hope
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Activation of heterologous gene expression by the large isoform of hepatitis delta antigen.

Authors:  Y Wei; D Ganem
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Functional analysis of ground squirrel hepatitis virus enhancer II.

Authors:  G Fourel; F Ringeisen; M Flajolet; P Tiollais; M A Buendia
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter.

Authors:  G Fourel; F Ringeisen; M Flajolet; F Tronche; M Pontoglio; P Tiollais; M A Buendia
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Woodchuck hepatitis virus enhancer I and enhancer II are both involved in N-myc2 activation in woodchuck liver tumors.

Authors:  M Flajolet; P Tiollais; M A Buendia; G Fourel
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection.

Authors:  William S Mason; Huey-Chi Low; Chunxiao Xu; Carol E Aldrich; Catherine A Scougall; Arend Grosse; Andrew Clouston; Deborah Chavez; Samuel Litwin; Suraj Peri; Allison R Jilbert; Robert E Lanford
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

9.  In vivo effects of mutations in woodchuck hepatitis virus enhancer II.

Authors:  Y Wei; B Tennant; D Ganem
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication.

Authors:  Laurence Colin; Nathalie Vandenhoudt; Stéphane de Walque; Benoît Van Driessche; Anna Bergamaschi; Valérie Martinelli; Thomas Cherrier; Caroline Vanhulle; Allan Guiguen; Annie David; Arsène Burny; Georges Herbein; Gianfranco Pancino; Olivier Rohr; Carine Van Lint
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.